The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Avastin Biosimilar Market Research Report 2024

Global Avastin Biosimilar Market Research Report 2024

Publishing Date : Jun, 2023

License Type :

Report Code : 1739056

No of Pages : 70

Ask Your Query

Report Description
Table of Content

Synopsis
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.

Global Avastin Biosimilar market is projected to reach US$ 471.5 million in 2029, increasing from US$ 1341 million in 2022, with the CAGR of -14.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Avastin Biosimilar market research.

Key manufacturers engaged in the Avastin Biosimilar industry include Celltrion, Amneal, Pfizer and Amgen, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Avastin Biosimilar were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Avastin Biosimilar market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Avastin Biosimilar market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

Celltrion
Amneal
Pfizer
Amgen

Segment by Type

400mg
100mg

Segment by Application

Cancer
Wet Age-related Macular Degeneration
Other

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Avastin Biosimilar report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Avastin Biosimilar Market Overview
1.1 Product Overview and Scope of Avastin Biosimilar
1.2 Avastin Biosimilar Segment by Type
1.2.1 Global Avastin Biosimilar Market Value Comparison by Type (2023-2029)
1.2.2 400mg
1.2.3 100mg
1.3 Avastin Biosimilar Segment by Application
1.3.1 Global Avastin Biosimilar Market Value by Application: (2023-2029)
1.3.2 Cancer
1.3.3 Wet Age-related Macular Degeneration
1.3.4 Other
1.4 Global Avastin Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Avastin Biosimilar Revenue 2018-2029
1.4.2 Global Avastin Biosimilar Sales 2018-2029
1.4.3 Global Avastin Biosimilar Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Avastin Biosimilar Market Competition by Manufacturers
2.1 Global Avastin Biosimilar Sales Market Share by Manufacturers (2018-2023)
2.2 Global Avastin Biosimilar Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Avastin Biosimilar Average Price by Manufacturers (2018-2023)
2.4 Global Avastin Biosimilar Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Avastin Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Avastin Biosimilar, Product Type & Application
2.7 Avastin Biosimilar Market Competitive Situation and Trends
2.7.1 Avastin Biosimilar Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Avastin Biosimilar Players Market Share by Revenue
2.7.3 Global Avastin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Avastin Biosimilar Retrospective Market Scenario by Region
3.1 Global Avastin Biosimilar Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Avastin Biosimilar Global Avastin Biosimilar Sales by Region: 2018-2029
3.2.1 Global Avastin Biosimilar Sales by Region: 2018-2023
3.2.2 Global Avastin Biosimilar Sales by Region: 2024-2029
3.3 Global Avastin Biosimilar Global Avastin Biosimilar Revenue by Region: 2018-2029
3.3.1 Global Avastin Biosimilar Revenue by Region: 2018-2023
3.3.2 Global Avastin Biosimilar Revenue by Region: 2024-2029
3.4 North America Avastin Biosimilar Market Facts & Figures by Country
3.4.1 North America Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Avastin Biosimilar Sales by Country (2018-2029)
3.4.3 North America Avastin Biosimilar Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Avastin Biosimilar Market Facts & Figures by Country
3.5.1 Europe Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Avastin Biosimilar Sales by Country (2018-2029)
3.5.3 Europe Avastin Biosimilar Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Avastin Biosimilar Market Facts & Figures by Country
3.6.1 Asia Pacific Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Avastin Biosimilar Sales by Country (2018-2029)
3.6.3 Asia Pacific Avastin Biosimilar Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Avastin Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Avastin Biosimilar Sales by Country (2018-2029)
3.7.3 Latin America Avastin Biosimilar Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Avastin Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Avastin Biosimilar Sales by Country (2018-2029)
3.8.3 Middle East and Africa Avastin Biosimilar Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Avastin Biosimilar Sales by Type (2018-2029)
4.1.1 Global Avastin Biosimilar Sales by Type (2018-2023)
4.1.2 Global Avastin Biosimilar Sales by Type (2024-2029)
4.1.3 Global Avastin Biosimilar Sales Market Share by Type (2018-2029)
4.2 Global Avastin Biosimilar Revenue by Type (2018-2029)
4.2.1 Global Avastin Biosimilar Revenue by Type (2018-2023)
4.2.2 Global Avastin Biosimilar Revenue by Type (2024-2029)
4.2.3 Global Avastin Biosimilar Revenue Market Share by Type (2018-2029)
4.3 Global Avastin Biosimilar Price by Type (2018-2029)
5 Segment by Application
5.1 Global Avastin Biosimilar Sales by Application (2018-2029)
5.1.1 Global Avastin Biosimilar Sales by Application (2018-2023)
5.1.2 Global Avastin Biosimilar Sales by Application (2024-2029)
5.1.3 Global Avastin Biosimilar Sales Market Share by Application (2018-2029)
5.2 Global Avastin Biosimilar Revenue by Application (2018-2029)
5.2.1 Global Avastin Biosimilar Revenue by Application (2018-2023)
5.2.2 Global Avastin Biosimilar Revenue by Application (2024-2029)
5.2.3 Global Avastin Biosimilar Revenue Market Share by Application (2018-2029)
5.3 Global Avastin Biosimilar Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Celltrion
6.1.1 Celltrion Corporation Information
6.1.2 Celltrion Description and Business Overview
6.1.3 Celltrion Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Celltrion Avastin Biosimilar Product Portfolio
6.1.5 Celltrion Recent Developments/Updates
6.2 Amneal
6.2.1 Amneal Corporation Information
6.2.2 Amneal Description and Business Overview
6.2.3 Amneal Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amneal Avastin Biosimilar Product Portfolio
6.2.5 Amneal Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Avastin Biosimilar Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amgen Avastin Biosimilar Product Portfolio
6.4.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Avastin Biosimilar Industry Chain Analysis
7.2 Avastin Biosimilar Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Avastin Biosimilar Production Mode & Process
7.4 Avastin Biosimilar Sales and Marketing
7.4.1 Avastin Biosimilar Sales Channels
7.4.2 Avastin Biosimilar Distributors
7.5 Avastin Biosimilar Customers
8 Avastin Biosimilar Market Dynamics
8.1 Avastin Biosimilar Industry Trends
8.2 Avastin Biosimilar Market Drivers
8.3 Avastin Biosimilar Market Challenges
8.4 Avastin Biosimilar Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}